Tuberculosis for Healthcare Providers

Forms

Tuberculosis Infection Reporting Form

Tuberculosis Disease Reporting: Please call (800) 472-2180 immediately.

Supplies Order Form 

Tuberculosis Medications and Pharmacy Information

Tuberculosis Disease Medication Request Form

Tuberculosis Infection Medication Request Form

Tuberculosis Infection Medication Start Date Form

Class Arrivals and Immigration 

TB Immigrant and Refugee Class Arrival Instructions

Guidelines

4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis (Feb. 25, 2022, Study)

Provisional CDC Guidance for the Use of Pretomanid as Part of a Regimen (Bedaquiline, Pretomanid, and Linezolid (BPaL) to Treat Drug-Resistant Tuberculosis Disease (Feb. 2, 2022)

The Spectrum of TB from Infection to Disease (3rd Edition, Heartland)

TB Close-Contact Factsheet (November 23, 2021 NDDoH)

ND Health Alert:  Health Advisory for Treatment for Tuberculosis—Nitrosamine Impurities in Rifampin & Rifapentine - Published October 16, 2020 (Broken link)

Tuberculosis Infection:  A Guide for Primary Healthcare Providers

Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat TB Infection - Updated June 29, 2018

Clinical Practice Guidelines:  Treatment of Drug Susceptible Tuberculosis - Published August 10, 2016

• Highlights from 2016 Treatment of Drug Susceptible TB Guidelines

Protocols

TB Risk Assessment for Adults

TB Risk Assessment for Pediatric Patients

TB Risk Assessment for Healthcare Workers